MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2–Positive and/or Hormone Receptor–Negative Breast Cancers in the I-SPY 2 Trial ...

It is deceptively simple to imagine that a curriculum’s effectiveness could be easily determined by a single well-designed study. Such a study would randomly assign students to two treatment groups, ...